NCT07005115

Brief Summary

The goal of this observational retrospective study is to assess whether serum lipid levels differ between patients diagnosed with lip squamous cell carcinoma (SCC) and healthy individuals. The study aims to evaluate if alterations in lipid parameters, especially LDL levels, are associated with the presence of lip SCC and could serve as potential early biomarkers. The main research questions are: Do patients with lip SCC show significantly lower LDL levels compared to healthy controls? Are there significant differences in total cholesterol (TC), triglycerides (TG), HDL, and VLDL between the two groups? A retrospective analysis was conducted using existing medical records of patients with lip SCC and healthy subjects obtained from 2018-2023.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

May 27, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 5, 2025

Completed
Last Updated

June 6, 2025

Status Verified

June 1, 2025

Enrollment Period

3 years

First QC Date

May 27, 2025

Last Update Submit

June 5, 2025

Conditions

Keywords

Oral CancerLipidsLipid LevelsNon-SmokersLip Squamous Cell Carcinoma

Outcome Measures

Primary Outcomes (1)

  • Low-Density Lipoprotein (LDL) Levels in Patients With Lip SCC vs. Healthy Controls

    To assess whether there is a statistically significant difference in fasting serum LDL levels between patients diagnosed with lip squamous cell carcinoma (SCC) and healthy subjects.

    At time of diagnosis (retrospective data collection)

Secondary Outcomes (4)

  • Total Cholesterol (TC) Levels in Patients With Lip SCC vs. Healthy Controls

    At time of diagnosis (retrospective data collection)

  • Triglycerides (TG) Levels in Patients With Lip SCC vs. Healthy Controls

    At time of diagnosis (retrospective data collection)

  • High-Density Lipoprotein (HDL) Levels in Patients With Lip SCC vs. Healthy Controls

    At time of diagnosis (retrospective data collection)

  • Very Low-Density Lipoprotein (VLDL) Levels in Patients With Lip SCC vs. Healthy Controls

    At time of diagnosis (retrospective data collection)

Study Arms (2)

study group

patients clinically evident and histopathologically confirmed with lip SCC

control group

subjects without any underlying systemic disease

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Data from patients with a histopathological diagnosis of primary lip cancers at Antalya Training and Research Hospital, Turkiye.

You may qualify if:

  • patients clinically evident and histopathologically confirmed with lip SCC (study group)
  • subjects without any underlying systemic disease (control group)

You may not qualify if:

  • Age younger than 18 years
  • pregnancy
  • smoking
  • history of radiotherapy or chemotherapy
  • family history of hyperlipidemia
  • accompanying malignancies other than lip SCC for both study and control groups

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Akdeniz University

Antalya, 07070, Turkey (Türkiye)

Location

Related Publications (15)

  • Lohe VK, Degwekar SS, Bhowate RR, Kadu RP, Dangore SB. Evaluation of correlation of serum lipid profile in patients with oral cancer and precancer and its association with tobacco abuse. J Oral Pathol Med. 2010 Feb;39(2):141-8. doi: 10.1111/j.1600-0714.2009.00828.x. Epub 2009 Dec 7.

    PMID: 20002982BACKGROUND
  • Kark JD, Smith AH, Hames CG. Serum retinol and the inverse relationship between serum cholesterol and cancer. Br Med J (Clin Res Ed). 1982 Jan 16;284(6310):152-4. doi: 10.1136/bmj.284.6310.152.

    PMID: 6799076BACKGROUND
  • Mehta R, Gurudath S, Dayansoor S, Pai A, Ganapathy KS. Serum lipid profile in patients with oral cancer and oral precancerous conditions. Dent Res J (Isfahan). 2014 May;11(3):345-50. doi: 10.4103/1735-3327.135889.

    PMID: 25097644BACKGROUND
  • Kumar P, Augustine J, Urs AB, Arora S, Gupta S, Mohanty VR. Serum lipid profile in oral cancer and leukoplakia: correlation with tobacco abuse and histological grading. J Cancer Res Ther. 2012 Jul-Sep;8(3):384-8. doi: 10.4103/0973-1482.103517.

    PMID: 23174719BACKGROUND
  • Gerber M, Richardson S, Crastes de Paulet P, Pujol H, Crastes de Paulet A. Relationship between vitamin E and polyunsaturated fatty acids in breast cancer. Nutritional and metabolic aspects. Cancer. 1989 Dec 1;64(11):2347-53. doi: 10.1002/1097-0142(19891201)64:113.0.co;2-v.

    PMID: 2804926BACKGROUND
  • Forones NM, Falcao JB, Mattos D, Barone B. Cholesterolemia in colorectal cancer. Hepatogastroenterology. 1998 Sep-Oct;45(23):1531-4.

    PMID: 9840100BACKGROUND
  • Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002 Jul-Aug;52(4):195-215. doi: 10.3322/canjclin.52.4.195.

    PMID: 12139232BACKGROUND
  • Patel PS, Shah MH, Jha FP, Raval GN, Rawal RM, Patel MM, Patel JB, Patel DD. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions. Indian J Cancer. 2004 Jan-Mar;41(1):25-31.

    PMID: 15105576BACKGROUND
  • Alexopoulos CG, Blatsios B, Avgerinos A. Serum lipids and lipoprotein disorders in cancer patients. Cancer. 1987 Dec 15;60(12):3065-70. doi: 10.1002/1097-0142(19871215)60:123.0.co;2-q.

    PMID: 3677028BACKGROUND
  • Acharya S, Rai P, Hallikeri K, Anehosur V, Kale J. Serum lipid profile in oral squamous cell carcinoma: alterations and association with some clinicopathological parameters and tobacco use. Int J Oral Maxillofac Surg. 2016 Jun;45(6):713-20. doi: 10.1016/j.ijom.2016.01.015. Epub 2016 Feb 19.

    PMID: 26899131BACKGROUND
  • Bota JP, Lyons AB, Carroll BT. Squamous Cell Carcinoma of the Lip-A Review of Squamous Cell Carcinogenesis of the Mucosal and Cutaneous Junction. Dermatol Surg. 2017 Apr;43(4):494-506. doi: 10.1097/DSS.0000000000001020.

    PMID: 28157733BACKGROUND
  • Moro JDS, Maroneze MC, Ardenghi TM, Barin LM, Danesi CC. Oral and oropharyngeal cancer: epidemiology and survival analysis. Einstein (Sao Paulo). 2018 Jun 7;16(2):eAO4248. doi: 10.1590/S1679-45082018AO4248.

    PMID: 29898090BACKGROUND
  • Han AY, Kuan EC, Mallen-St Clair J, Alonso JE, Arshi A, St John MA. Epidemiology of Squamous Cell Carcinoma of the Lip in the United States: A Population-Based Cohort Analysis. JAMA Otolaryngol Head Neck Surg. 2016 Dec 1;142(12):1216-1223. doi: 10.1001/jamaoto.2016.3455.

    PMID: 27832256BACKGROUND
  • Louredo BV, Vargas PA, Perez-de-Oliveira ME, Lopes MA, Kowalski LP, Curado MP. Epidemiology and survival outcomes of lip, oral cavity, and oropharyngeal squamous cell carcinoma in a southeast Brazilian population. Med Oral Patol Oral Cir Bucal. 2022 May 1;27(3):e274-e284. doi: 10.4317/medoral.25147.

    PMID: 35368013BACKGROUND
  • Tranby EP, Heaton LJ, Tomar SL, Kelly AL, Fager GL, Backley M, Frantsve-Hawley J. Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data. Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1849-1857. doi: 10.1158/1055-9965.EPI-22-0114.

    PMID: 35732291BACKGROUND

MeSH Terms

Conditions

Carcinoma, Squamous CellLip NeoplasmsMouth Neoplasms

Condition Hierarchy (Ancestors)

CarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsNeoplasms, Squamous CellHead and Neck NeoplasmsNeoplasms by SiteLip DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Eldar Rasljanin, DDS

    Akdeniz University, Antalya, Turkiye

    PRINCIPAL INVESTIGATOR
  • Özer Erdem Gür, MD

    Antalya Training and Research Hospital, University of Health Science, Antalya, Turkiye

    PRINCIPAL INVESTIGATOR
  • Rezarta Taga Senirli, MD

    Antalya Training and Research Hospital, University of Health Science, Antalya, Turkiye

    PRINCIPAL INVESTIGATOR
  • Busehan Bilgin, DDS

    Akdeniz University, Antalya, Turkiye

    PRINCIPAL INVESTIGATOR
  • Öznur Özalp, DDS

    Akdeniz University, Antalya, Turkiye

    PRINCIPAL INVESTIGATOR
  • Mehmet Ali Altay, DDS, PhD

    Akdeniz University, Antalya, Turkiye

    PRINCIPAL INVESTIGATOR
  • Alper Sindel, DDS, PhD

    Akdeniz University, Antalya, Turkiye

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 27, 2025

First Posted

June 5, 2025

Study Start

January 1, 2018

Primary Completion

January 1, 2021

Study Completion

January 1, 2023

Last Updated

June 6, 2025

Record last verified: 2025-06

Locations